Across TCGA pan-cancer cohorts, CATSPERZ Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CATSPERZ data layer compared with 20 for mass-spec protein.
The strongest signal is observed in esophageal carcinoma (ESCA), where higher CATSPERZ Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CATSPERZ expression acts as an unfavorable survival marker.
ESCA and UCEC are the cancer types where CATSPERZ Mutation most reproducibly stratifies survival.